Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. - Wikidata - awgldk - TriplyDB

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

http://www.wikidata.org/entity/Q30448605

about

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome Renal Denervation: A Potential Novel Treatment for Type 2 Diabetes Mellitus?Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information Muscle Sympathetic Nerve Activity Is Associated with Liver Insulin Sensitivity in Obese Non-Diabetic Men.Non-contact radiofrequency-induced reduction of subcutaneous abdominal fat correlates with initial cardiovascular autonomic balance and fat tissue hormones: safety analysis Cardiac β-Adrenoceptor Expression Is Reduced in Zucker Diabetic Fatty Rats as Type-2 Diabetes Progresses Response to Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.Food-intake dysregulation in type 2 diabetic Goto-Kakizaki rats: hypothesized role of dysfunctional brainstem thyrotropin-releasing hormone and impaired vagal output.Effects of aerobic conditioning on cardiovascular sympathetic response to and recovery from challenge Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity.Norepinephrine transporter expression is inversely associated with glycaemic indices: a pilot study in metabolically diverse persons with overweight and obesity.Is diabetic cardiomyopathy a specific entity?Effects of renal denervation on insulin resistance.Noradrenaline transmission reducing drugs may protect against a broad range of diseases.Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?Cardiometabolic crosstalk in obesity-associated arterial hypertension.Adrenergic signaling in heart failure and cardiovascular aging.Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus.Hyperglycemia induces defective Ca2+ homeostasis in cardiomyocytes.The influence of reduced insulin sensitivity via short-term reductions in physical activity on cardiac baroreflex sensitivity during acute hyperglycemia.The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia.Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy.Hepatic denervation and dyslipidemia in obese Zucker (fa/fa) rats.Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter.Long-term effects of baroreflex activation therapy on glucose metabolism.Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance.Carbohydrate ingestion induces sex-specific cardiac vagal inhibition, but not vascular sympathetic modulation, in healthy older women.Carbohydrate ingestion induces differential autonomic dysregulation in normal-tension glaucoma and primary open angle glaucoma.The Glymphatic System in Diabetes-Induced Dementia

P2860

Q21284498-0A62C026-B34E-4E85-A5EC-FC7B8351E1BA Q26778196-3F44A1D6-5677-4BF1-9548-FF002DFC1269 Q26795624-F0591E65-D2C0-438B-ABEE-8AC348E404CE Q27011347-74CA90B0-08A9-4486-B350-1BF076FBCDF0 Q29248634-1144D01D-20BE-4F82-864E-7739AAFF6845 Q30361143-34011882-05AA-40BB-BDA5-CAE0ACC50E5B Q35605582-7FFC9D03-BFEA-45D5-BA9D-CBF0B8BC6562 Q35637980-4F5FCC47-B98E-4D2A-BD67-67C558006654 Q36477306-DF24119A-0339-4FED-B380-95140A00F612 Q36477329-F45AB200-6CE2-4713-A722-504149A10D1A Q37042846-0571F114-E74B-4A9D-ADF9-ED38FBB8934A Q37273912-ABE7BEB6-5369-488D-B56E-1F59C9EFF541 Q37323375-91463E74-C891-4DDD-8081-213AF45331DD Q37343943-CB471B8D-F537-41B9-B0F2-AB2BC9473739 Q37575998-82396B47-C31F-49EC-8220-634AFE0460EB Q38067774-BADCA381-1BC6-434D-ADA3-DB646BD63BF5 Q38255794-6129526C-1BC3-46B4-AF70-2A53A9E9CCB7 Q38484107-934449DA-4289-4427-84AD-1EDE61AA9D91 Q38767511-686ECE84-1EDC-4ABA-ADD0-E53B37C3BC48 Q38803622-90885076-4C6B-4449-9D68-8E24BBA669B1 Q38879588-31C749D1-C9AD-4679-99E7-06FD4DBF67B1 Q38908684-696C18B8-C227-40E3-8752-DFD4FAAC91ED Q39158044-B3684F45-B53D-43F7-AEA5-37D472266A00 Q40425449-5E309B84-B176-43F0-8A3D-C0EEA4B9D3D4 Q45826353-C132660A-F5FE-49DB-9AFE-906105322BC8 Q47436179-74545DC9-8B65-46F7-AA39-FB2B51446550 Q48099387-4F86CA03-1E6F-447C-B29F-A037CB12A558 Q48486475-4C67C0B7-3CF0-467F-A029-86DE531BCF77 Q51310486-ACCDBB1E-7002-4D96-8329-93F9050A45CB Q53492192-AB39C5F3-BBAD-4925-8489-3D2F79BE9872 Q53787410-2123121D-7308-4DCE-8D7E-2594C4E53DE1 Q55405778-3D71E578-BD47-4935-A512-D37E1A5F98A6 Q59133635-26A98375-5C2A-4B93-98D7-B49B06D1A114

P2860

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

http://www.wikidata.org/entity/Q30448605

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Neuroadrenergic dysfunction al ...... e metabolic syndrome subjects.

@ast

Neuroadrenergic dysfunction al ...... e metabolic syndrome subjects.

@en

type

label

Neuroadrenergic dysfunction al ...... e metabolic syndrome subjects.

@ast

Neuroadrenergic dysfunction al ...... e metabolic syndrome subjects.

@en

prefLabel

Neuroadrenergic dysfunction al ...... e metabolic syndrome subjects.

@ast

Neuroadrenergic dysfunction al ...... e metabolic syndrome subjects.

@en

P1433

Q30448605-05EDF1E6-226A-4EF4-BCB2-FDF2BE77D1BB

P1476

Q30448605-EC2E43CF-67C1-4C35-90D0-5AF69714D81B

P2093

Q30448605-00DCFE2C-B75A-42AE-9487-FE1D470F20B0

Q30448605-015A23F0-B6CF-45F5-8BFE-7102B22E32C4

Q30448605-25EB4F8D-1945-42ED-B832-ED7242DAD1A0

Q30448605-6301E7B3-3412-4053-9F9A-A542388950A1

Q30448605-9451F2C3-FAD6-4A99-8486-46F68EFDEE9A

Q30448605-AF9B6711-7B38-4BBD-BFFF-522482C49E4E

Q30448605-D26BC2FE-81E7-48B5-BD01-D59810951DBC

Q30448605-D4EB296B-B0F9-4EB1-8690-72A04FC4DF1C

Q30448605-D6928835-608D-4939-AA8B-F7B245F50CEB

Q30448605-EA7AD184-5EA4-498B-83EC-679FFD3172BB

P2860

Q30448605-02B2DA85-533F-41C1-9222-F8D04EF1AC0C

Q30448605-04D19EAC-9990-43F5-AE60-F42506C22835

Q30448605-0A64ED65-088B-498E-AD8E-89667EF72877

Q30448605-117B0CA7-8390-4DB2-B1D9-889C68CAC7A8

Q30448605-2B3A225E-6A83-49EE-97B6-2B92A2BBD93B

Q30448605-2D90CE60-C4CA-42CB-9A80-A335F922301B

Q30448605-3A7F6C94-33BA-4D41-ABA0-AB2B2FC58094

Q30448605-43B8D7BD-9DED-4EA0-B363-AB0EC306ED16

Q30448605-4AFF7C90-7A4A-4F90-8127-41DEE3FBD0EF

Q30448605-4F2232B2-CAFD-4BFA-9F09-DEE04D3CFF5A

P304

Q30448605-DBB7CAE9-554E-4184-A56C-41C082A3FED1

P31

Q30448605-9EA77F39-C870-404C-B857-9F54E01B29BE

P356

Q30448605-9B49C978-7A5E-4B88-8A27-BD55C93597EA

P407

Q30448605-52A8AE17-BF91-432F-A206-6F0F1042D19A

P433

Q30448605-3538CC08-9D68-4C3D-8472-FEB1DE9A3992

P478

Q30448605-1278AABC-B8CF-447A-86F1-0CA2111C9770

P50

Q30448605-315BA99C-1D42-4898-BC77-FFA05FE98548

Q30448605-D851C156-77F5-4544-B043-7CC62DC74508

P577

Q30448605-F4311158-BB61-4294-AAD0-3E0F9B5580C7

P5875

Q30448605-ACC81363-7359-4CBC-B740-452C0A9AEA09

P698

Q30448605-9D9B3A16-F3F4-403B-8ADF-7B0FA719FAAF

P921

Q30448605-528A5F80-1E32-48BF-BE79-816FD390EE77

Q30448605-7B7E74C9-5FDF-41E9-B2FA-D73751E55697

P932

Q30448605-DC531BAF-C6C9-4741-8A9C-25393F9331D3

P356

P1433

P1476

Neuroadrenergic dysfunction al ...... e metabolic syndrome subjects.

@en

P2093

Carolina I Sari

http://www.w3.org/2001/XMLSchema#string

Gavin W Lambert

http://www.w3.org/2001/XMLSchema#string

John B Dixon

http://www.w3.org/2001/XMLSchema#string

Mariee T Grima

http://www.w3.org/2001/XMLSchema#string

Markus P Schlaich

http://www.w3.org/2001/XMLSchema#string

Murray D Esler

http://www.w3.org/2001/XMLSchema#string

Nina Eikelis

http://www.w3.org/2001/XMLSchema#string

Nora E Straznicky

http://www.w3.org/2001/XMLSchema#string

Paul J Nestel

http://www.w3.org/2001/XMLSchema#string

Reena Chopra

http://www.w3.org/2001/XMLSchema#string

P2860

Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients.

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects

Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis

Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function

Global estimates of the prevalence of diabetes for 2010 and 2030

Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans

Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Sympathetic nervous system and insulin resistance: from obesity to diabetes.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

P304

2506-2516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB12-0138

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

Elisabeth Lambert

P577

2012-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225185966

http://www.w3.org/2001/XMLSchema#string

P698

22664956

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3447913

http://www.w3.org/2001/XMLSchema#string